ROCKAWAY, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that its gammaCore™ nVNS device has received ...

Staff Sgt. Dominic Anderson demonstrates the gammaCore device, looking at a screen with various tasks the study group had to do. According to researchers at Wright-Patterson Air Force Base, a handheld ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted breakthrough device designation to electroCore Inc. for its gammaCore device to be used in ...

ROCKAWAY, N.J., April 07, 2026 (GLOBE NEWSWIRE)-- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the enrollment of the first eight ...

A study published in the Journal of Headache and Pain, carried out by Dr. Thomas Kinfe of the University of Bonn, found that twice daily stimulation of the vagus nerve with the hand-held gammaCore ...

The device, which just received approval from the U.S. Food and Drug Administration (FDA), is called GammaCore. People who suffer from a severe form of headache called cluster headaches now have a new ...

Vagus nerve stimulation has moved from a clinical curiosity into the consumer wellness mainstream. Five years ago, the o ...